back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-03 14:17 Tx date 2025-05-29 |
$MDMA
Pharmala Biotech Holdings Inc. |
Tsergas, Perry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
200,000 | |
| Filed 2025-03-20 12:31 Tx date 2025-03-17 |
$MDMA
Pharmala Biotech Holdings Inc. |
Tsergas, Perry
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+37,500 vol |
356,000 | |
| Filed 2025-03-20 12:31 Tx date 2025-03-17 |
$MDMA
Pharmala Biotech Holdings Inc. |
Tsergas, Perry
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-37,500 vol |
0 | |
| Filed 2024-12-10 14:06 Tx date 2024-12-09 |
$MDMA
Pharmala Biotech Holdings Inc. |
Tsergas, Perry
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+37,500 vol |
318,500 | |
| Filed 2024-12-10 14:06 Tx date 2024-12-09 |
$MDMA
Pharmala Biotech Holdings Inc. |
Tsergas, Perry
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-37,500 vol |
37,500 | |
| Filed 2024-12-02 19:29 Tx date 2024-11-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
Tsergas, Perry
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+75,000 vol |
281,000 | |
| Filed 2024-12-02 19:28 Tx date 2024-11-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
Tsergas, Perry
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-75,000 vol |
75,000 | |
| Filed 2024-11-25 10:25 Tx date 2024-11-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Tsergas, Perry
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,760
-44,000 vol $0.29 each |
206,000 | |
| Filed 2024-11-21 12:40 Tx date 2024-11-19 |
$MDMA
Pharmala Biotech Holdings Inc. |
Tsergas, Perry
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,500
+250,000 vol $0.05 each |
250,000 | |
| Filed 2024-11-21 12:40 Tx date 2021-03-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Tsergas, Perry
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-11-21 12:39 Tx date 2024-11-19 |
$MDMA
Pharmala Biotech Holdings Inc. |
Tsergas, Perry
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-12,500
-250,000 vol $0.05 each |
100,000 | |
| Filed 2024-03-02 19:11 Tx date 2024-02-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
Tsergas, Perry
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+150,000 vol |
150,000 | |
| Filed 2024-03-02 19:10 Tx date 2021-03-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Tsergas, Perry
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|